©1995 by The American Society for Biochemistry and Molecular Biology, Inc.
Angiotensin II Receptor Endocytosis Involves Two Distinct Regions of the Cytoplasmic Tail
A ROLE FOR RESIDUES ON THE HYDROPHOBIC FACE OF A PUTATIVE AMPHIPATHIC HELIX (*)

(Received for publication, May 8, 1995; and in revised form, July 17, 1995)

Walter G. Thomas (§) Kenneth M. Baker (¶) Thomas J. Motel Thomas J. Thekkumkara (**)

From the Weis Center for Research, Geisinger Clinic, Danville, Pennsylvania 17822

ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
FOOTNOTES
REFERENCES

ABSTRACT

Following agonist stimulation, many receptors are rapidly internalized from the plasma membrane via a mechanism which presumably involves recognition motifs within the cytoplasmic domains of the receptor. We have previously demonstrated (Thomas, W. G., Thekkumkara, T. J., Motel, T. J., and Baker, K. M. (1995) J. Biol. Chem. 270, 207-213) that truncation of the angiotensin II (AT) receptor, to remove 45 amino acids from the cytoplasmic tail, markedly reduced agonist stimulated receptor endocytosis. In the present study, we have stably and transiently expressed wild type and carboxyl terminus mutated AT receptors in Chinese hamster ovary cells to identify regions and specific amino acids important for this process. Wild type AT receptors rapidly internalized (t = 2.5 min; Y(max) = 76.4%) after AII stimulation. Using AT receptor mutants, truncated and deleted at the carboxyl terminus, two distinct regions important for internalization were identified: one membrane proximal site between residues 315-329 and another distal to Lys, within the terminal 26 amino acids. Point mutations (Y302A, Y312A, L316F, Y319A, and K325A) were performed to identify residues contributing to the membrane proximal site. Mutation of Y302A, Y312A, and K325A had little effect on the rate (t = 4.3, 2.8, and 2.8 min) and maximal amount (Y(max) = 81.7, 67.8, and 73.5%) of AII induced internalization. In contrast, L316F and Y319A mutations displayed an approximately 2.5-fold reduction in rate (t = 6.1 and 6.2 min) and L316F a decreased maximal level (Y(max) = 38.1 and 71.4%, respectively) compared to wild type. Interestingly, Leu and Tyr are closely aligned within the hydrophobic aspect of a putative amphipathic helix, possibly representing an internalization motif for the AT receptor. We conclude that the AT receptor does not use the NPXXY (NPLFY) motif, first described for the beta(2)-adrenergic receptor, to mediate agonist stimulated endocytosis. Rather, two distinct regions of the carboxyl terminus are utilized: one involving hydrophobic and aromatic residues on a putative alpha-helix and another serine/threonine-rich domain.


INTRODUCTION

Endocytosis of cell surface receptors is a ubiquitous eukaryotic process. It permits the internalization of extracellular nutrients (e.g. cholesterol via low density lipoprotein receptors), serves to dampen cell responses by removing ligand-activated receptors from the cell surface, and mediates cellular resensitization by recycling functional receptors to the cell surface(1, 2, 3, 4, 5, 6) . Although some endocytosis occurs constitutively, the rate is increased dramatically following binding of many extracellular ligands to their cognitive transmembrane receptors. This process is homologous in that usually only receptors for the stimulating ligand are internalized, and of those, only receptors occupied by ligand are targeted. Homologous endocytosis predicts that receptors inherently contain within their structures and sequences determinants for internalization, and that these determinants are concealed or remain latent until agonist binding. Thus, it is generally assumed that within the cytoplasmic domains of receptors are one or more amino acid codes, or motifs, that are recognized by adaptor complexes which mediate the selective recruitment of receptor-ligand complexes into primarily clathrin-coated vesicles (3, 5, 7, 8) or non-coated vesicles and caveolae (discussed in (9) ). Commonly, these motifs include aromatic (predominantly tyrosine) and hydrophobic amino acids, and while phosphorylation of these crucial tyrosines does not necessarily drive the internalization process, phosphorylation at other sites may initiate allosteric changes within the receptor responsible for unmasking endocytotic codes (10, 11, 12) .

Angiotensin II (AII) (^1)is a peptide hormone with important actions on blood pressure regulation, water and salt balance, neuromodulation, and cellular growth(13) . Two major types of AII receptors, termed AT(1) and AT(2), and two subtypes of the AT(1) receptor, termed AT and AT, have been identified(14) . These receptors are all members of the seven transmembrane, guanyl nucleotide-binding protein (G-protein)-coupled receptor (GPCR) superfamily, but the AT receptor, which contains 359 amino acids including approximately 54 amino acids as a carboxyl-terminal cytoplasmic tail, is the principal mediator of the biological actions of AII. AII receptors present on cells cultured from various tissues (15, 16, 17, 18, 19) and cloned AT and AT(20, 21, 22, 23, 24) , but not AT(2)(23) , receptors expressed in cell systems, rapidly internalize upon AII binding. Internalization of AIIbulletreceptor complexes is independent of G-protein coupling (20, 22) and occurs via a clathrin-dependent process(20) , which is the primary route for many, but not all, GPCRs. While the exact cellular processes and receptor motifs that control AT receptor endocytosis are unknown, the AT carboxyl terminus contains four candidate tyrosine residues (Tyr, Tyr, Tyr, and Tyr). Interestingly, Tyr in the motif NPXXY is analogous to Tyr shown to be important for beta(2)-adrenergic receptor internalization(25) , but the contribution of Tyr to AT receptor endocytosis has not been reported. The serine/threonine-rich portion of the carboxyl terminus has been implicated in AT receptor internalization(23) , and we recently demonstrated that truncation of the AT receptor to delete the carboxyl-terminal 45 amino acids markedly reduced agonist-mediated endocytosis(24) . In the present study, we have stably and transiently expressed in CHO-K1 cells AT receptors containing truncation, deletion, and point mutations of the cytoplasmic tail and determined AII stimulated endocytosis. Our data implicate two separate domains within the carboxyl-terminal region of the AT receptor in endocytosis and identify key amino acids involved in this process.


EXPERIMENTAL PROCEDURES

Reagents and Cell Culture Materials

I-AII (specific activity >2000 Ci/mmol) was purchased from DuPont NEN or Hazelton Laboratories (Vienna, VA). Chinese hamster ovary cells (CHO-K1) were obtained from the American Type Culture Collection (Rockville, MD). The Escherichia coli strain XL1-blue and pBluescript II vector were obtained from Stratagene (La Jolla, CA). Sequenase 2.0 DNA sequencing kits were from U. S. Biochemical Corp. and the pRc/CMV vector was from Invitrogen (San Diego, CA). alpha-MEM, OPTI-MEM, fetal bovine serum, the antibiotic geneticin (G418), other cell culture additives and plasticware, and lipofectamine were obtained from Life Sciences. DNA modifying enzymes were from Promega (Madison, WI). All other chemicals were from Fisher or Sigma.

Receptor Constructs and Mutagenesis

We have previously reported the cloning and isolation of a genomic clone for the rat AT receptor (12), subcloning of the full-length receptor (coding for 359 amino acids) into pBluescript II (pB2/AT) and the subsequent incorporation of the receptor into the pRc/CMV eukaryotic expression vector (pRc2A/AT) (26) . The construction of an AT receptor with a stop codon after Leu, which codes for a receptor missing 45 amino acids from the carboxyl terminus, subcloning into pRc/CMV (pRc/TL314) and stable expression of this truncated receptor in CHO-K1 cells (TL314) has been previously described(24) .

To truncate the AT receptor after Lys, a 1126-base pair fragment was PCR amplified from the clone pB2/AT using a sense primer (5`-GTAAAGCTTAAGTGGATTTCG-3`) and antisense primer (5`-GGTAGAAAGCTTGCTCTATTTCGTAGAC-3`), incorporating HindIII restriction sites (underlined) and an antisense stop codon (italics) after Lys. The amplified DNA was restriction digested with HindIII and subcloned directly into the pRc/CMV vector (pRc/TK333). Sequencing with the Sequenase 2.0 kit, as described previously(26) , confirmed the correct orientation and the entire coding region. Deletion of 15 amino acids (Glu through Ser) from the full cytoplasmic tail was constructed in two steps. First, a 1012-base pair fragment was PCR amplified from the clone pB2/AT using the same sense primer as above and an antisense primer (5`-TTTCAGGAGCTCGAGGAAATACTT-3`), incorporating a XhoI site (underlined). The PCR fragment, coding for amino acids 1-314, was restriction digested with HindIII and XhoI and subcloned into pBluescript II (pB/1-314). Second, a DNA fragment, coding for amino acids 330-359, was PCR amplified from pB2/AT using a sense primer (5`-TCCTGTCTACGAAAATGAGCACG-3`) and an antisense primer (5`-CTACAGTCTGATGGGCCCATTTTTCTGCTTAG-3`), incorporating an ApaI restriction site (underlined). pB1-314 was digested with XhoI, blunted using mung bean nuclease and a second restriction digest performed with ApaI. The second PCR product was digested with ApaI and ligated into the modified pB1-314. The integrity of the deletion mutant construct was confirmed by sequencing and then released by an ApaI/HindIII digest for cloning into pRc/CMV (pRc/Del315-329).

Point mutations were introduced into the AT receptor using the PCR-based method of Ito et al.(27) . Tyrosines at positions 302, 312, and 319 and lysine at position 325 were individually mutated to alanine, and leucine at position 316 was mutated to phenylalanine, using the following primers (mutated bases are underlined): Y302A, 5`-AACCCTCTGTTCGCCGGCTTTCTG-3`; Y312A, 5`-GAAATTTAAAAAGGCTTTCCTCCAG-3`; L316F, 5`-GTATTTCCTCCAGTTCCTGAAATAT-3`; Y319A, 5`-CAGCTCCTGAAAGCTATTCCCCCAAAG-3`; K325A, 5`-CCCCCAAAGGCCGCGTCCCACTCA-3`.

All mutated PCR fragments were cloned into pBluescript II and the entire coding region and the relevant mutation confirmed by sequencing. Mutated receptor sequences were restriction digested with HindIII and subcloned into pRc/CMV at the same site to yield the expression plasmids pRc/Y302A, pRc/Y312A, pRc/L316F, pRc/Y319A, and pRc/K325A.

Stable and Transient Transfections

CHO-K1 cells were maintained in alpha-MEM containing fetal bovine serum (10%), penicillin G sodium (100 µg/ml), streptomycin sulfate (100 µg/ml), and amphotericin B (0.25 µg/ml) (complete medium). CHO-K1 cells (50% confluent in 100-mm dishes) were transfected with 20 µg of plasmid DNA for wild type or mutated receptors using the Polybrene method as described previously(24) . Transfected cultures were maintained in the presence of 800 µg G418/ml of complete medium for 10-14 days to select for plasmid containing cells, and individual clones were picked for propagation. Clonal lines were maintained under a selection pressure of 200 µg G418/ml and tested for the capacity to bind I-AII as described(24) . Multiple clones expressing wild type or mutated receptor were obtained. Results for individual clones, chosen for full characterization and the internalization experiments described herein, were confirmed in one or two other clones.

The authenticity of the data obtained from the clonal lines was also confirmed using transient transfections. For this, CHO-K1 cells at 80% confluence, in 35-mm dishes, were transfected using the lipofectamine method, as described by the manufacturer (Life Sciences). Cells were washed in OPTI-MEM, and for each well 1 µg of plasmid DNA was mixed with 8 µl of the lipofectamine reagent (2 mg/ml) in 200 µl of OPTI-MEM for 20 min. The mixture was diluted to 1 ml with OPTI-MEM and placed on the washed cells, which were returned to the incubator for 5 h. The DNA/lipofectamine solution was aspirated and replaced with 3 ml of complete media. Cells were cultured for 48 h and internalization assays performed. For each transfection, I-AII binding assays were performed in parallel on some wells to confirm transfection efficiency and receptor expression. The level of receptor expression, extrapolated by assuming similar dissociation constants established for the clonal cell lines, was approximately 400-600 fmol/mg protein for the wild type receptors and 100-400 fmol/mg protein for the mutants.

AII Binding Studies

AII binding studies were performed on cultures of transfected CHO-K1 cells in 12-well culture plates as described previously(28) . The AII receptor binding buffer contained 50 mM Tris-HCl, pH 7.5, 120 mM NaCl, 4 mM KCl, 5 mM MgCl(2), 1 mM CaCl(2), 10 µg/ml Bacitracin, and 2 mg/ml D-glucose. Receptor affinity and density were determined by competition binding studies in the presence of 40 pMI-AII and increasing concentrations (1 pM to 10 µM) of unlabeled AII.

Determination of Receptor Internalization

Clonal cell lines, stably expressing wild type or mutated receptors, were grown in triplicate to confluence in 12-well culture plates. The rate and degree of agonist-induced endocytosis was determined as follows: cells were washed three times with Hank's buffered salt solution, covered with 0.9 ml of AII receptor binding buffer (prewarmed to 37 °C), and the plates returned to 37 °C for 30 min. I-AII, in 100 µl of binding buffer, was added to a final concentration of 0.4-0.6 nM, and the incubation continued at 37 °C for 2, 5, 10, and 20 min. At each time point, plates were chilled on ice and washed five times with 1.0 ml of ice-cold binding buffer to prevent further internalization and to remove unbound I-AII. Bound I-AII associated with non-internalized receptors in the plasma membrane was removed by two 40-s washes with 5 mM ice-cold acetic acid in 150 mM NaCl, pH 2.5. These acid washes were retained, and the internalized radioactivity was collected by adding 1.0 ml of 0.2 M NaOH, 0.25% sodium dodecyl sulfate to each well and washing with an additional 0.5 ml of the same solution. Radioactivity in the acid-sensitive and -insensitive fractions was measured with a LKB CompuGamma counter. After correction for background radioactivity associated with the parental untransfected CHO-K1 cells performed in parallel, an index of receptor internalization was obtained by expressing the acid-insensitive counts as a percentage of the total binding (acid-insensitive plus acid-sensitive) for each well. For transient transfections, the level of internalization was determined as above, but only at the 10-min time point.

Analysis of the Data

Non-linear regression analysis of the competition binding data was achieved using the computer software GraphPad Prism (GraphPad Software Inc.); dissociation constants (K(d)) and receptor density (B(max)) were estimated as described(29) . For endocytosis assays, the percentage of internalized receptors was plotted against time, and the curves analyzed as one phase exponential associations using GraphPad Prism. The half-time (t in min) to reach a maximal level of internalization (Y(max) in %) was determined for each association curve.

Computer Modeling

Secondary structure predictions for the carboxyl-terminal region of the AT receptor were obtained via the PHDsec server (Email: Predictprotein@EMBL-Heidelberg.DE). Full description of the server and the prediction algothrim have been published(30, 31, 32) .


RESULTS

cDNAs encoding wild type and mutated rat AT receptors were subcloned into the pRc/CMV mammalian expression vector and transfected into CHO-K1 cells. The various constructs are depicted in Fig. 1. Colonies resistant to neomycin (G418) were selected and propagated, and individual clonal lines expressing functional receptors were selected by the ability to bind I-AII. To determine if the expressed mutated receptors displayed affinities comparable to the wild type receptor, competition binding studies were performed. As summarized in Table 1, the wild type and assorted truncation, deletion, and point substitution mutants all bound I-AII with high affinity (K(d) approximating 1 nM) indicating that these receptors attain a conformation necessary for high affinity recognition of AII. Dissociation constant values in the nanomolar range compare well with those previously reported for AT(1) receptors expressed in cells and tissues(33) . The level of receptor expression for the mutated receptors ranged between 145-840 fmol/mg protein (Table 1).


Figure 1: Schematic representation of the wild type rat AT receptor and mutations to the carboxyl-terminal region. The top of the figure illustrates the predicted seven transmembrane topology of the receptor, with residues 298 through 359, which comprise the end of the seventh transmembrane segment and the entire carboxyl-tail, shown as open circles. The bottom of the figure is the one-letter amino acid representation for residues 298 to 359 for the wild type, truncated, deleted, and point-mutated constructs. The end of the seventh transmembrane segment is indicated (TM7) on the wild type sequence. For point mutations, the specific residue changed is underlined and the substitution indicated above.





Using the appearance of acid-resistant radioactivity, after addition of I-AII at 37 °C as an index of receptor internalization, we observed that wild type AT receptors expressed in CHO-K1 cells underwent rapid endocytosis from the plasma membrane (Fig. 2). Shown in Fig. 2is the internalization profile for four separate clonal lines (T3, T5, T11, and T24) expressing the wild type receptor. Although the level of expression in these clones varies over a 10-fold range (T3, 3400 fmol/mg protein(26) ; T24, 667 fmol/mg protein(24) ; T11, 330 fmol/mg protein; T5, 310 fmol/mg protein), the kinetics of I-AII internalization, fitted as one phase exponential associations, were similar for all four clonal lines (T3, t 2.1 min, Y(max) 80.9%; T5, t 2.3 min, Y(max) 79.4%; T11, t 2.3 min, Y(max) 80.6%; T24, t 2.5 min, Y(max) 76.4%). This observation indicates that the level of receptor expression does not influence the degree of agonist-stimulated endocytosis and therefore internalization parameters for the mutant receptors can be directly compared despite varying levels of receptor expression (145-840 fmol/mg protein). One of the wild type receptor expressing clones, T24, was chosen for comparison with cells expressing mutated receptors. Also shown in Fig. 2is the markedly reduced internalization (Y(max) 16.2%) of TL314, confirming our previous observation (24) that the carboxyl-terminal 45 amino acids of the AT receptor play a critical role in endocytosis. It is noteworthy that removal of 45 amino acids from the cytoplasmic tail did not prevent high affinity binding of AII, coupling to G-proteins, and appropriate activation of conventional signaling pathways(24) .


Figure 2: Endocytosis of the AT receptor is independent of receptor density but dependent upon an intact carboxyl terminus. CHO-K1 cells stably expressing varying densities of wild type AT receptor (T3, 3400 fmol/mg protein, filled circles; T5, 310 fmol/mg protein, open circles; T11, 330 fmol/mg protein, filled squares; T24, 667 fmol/mg protein, open squares) or a carboxyl-truncated AT receptor (TL314, crosses) were incubated with I-AII for 2-20 min at 37 °C. At the indicated times, surface-bound and internalized I-AII were determined by acid washing as described under ``Experimental Procedures.'' An index of internalization was calculated by expressing the internalized radioactivity (acid-resistant) as a percentage of the total binding (acid-resistant plus acid-susceptible). Data are means ± S.D. for three (TL314), six (T3, T5, and T11) or nine (T24) determinations.



To further define sites important for internalization (within this carboxyl-terminal region), we evaluated the capacity of another truncated receptor, TK333, to undergo AII-mediated endocytosis (Fig. 3). This mutant displayed a slower (t 6.1 min) and reduced amount (Y(max) 46.3%) of internalization compared to the wild type T24 (t 2.5 min, Y(max) 76.4%), implicating the terminal 26 amino acids in the internalization process. However, the level of internalization observed for TK333 was consistently greater than that observed for TL314 (Y(max) 46.3 versus 16.2% (see Fig. 2)), which suggested that the region between Leu and Lys also contained an endocytotic determinant. To confirm this, a deletion mutant was constructed in which the terminal 30 amino acids(330-359) were fused to the first 314 residues, deleting amino acids 315-329. As shown in Fig. 3, I-AII was slowly (t = 8.6 min) internalized by this mutant, to a degree (Y(max) = 40.9%) slightly less than that displayed by TK333. These observations suggest that there are two sites important for endocytosis within the carboxyl terminus of the AT receptor; one distal to Lys and another in the region 315-329.


Figure 3: Two separate regions of the AT receptor carboxyl terminus are important for endocytosis. Internalization kinetics for the wild type AT receptor (filled circles) and truncated (TK333, open circles) and deletion (Del315-329, squares) mutants were obtained as described in the legend to Fig. 1. Data are the means ± S.D. from three separate experiments performed in triplicate.



While these observations were being made, Hunyady et al.(23) reported the inhibition of AT receptor internalization by mutation of amino acids within a carboxyl-terminal serine/threonine-rich region, in particular, residues Ser, Thr, and Leu. The location of these residues distal to our truncation of the receptor at Lys explained the diminished internalization observed for TK333. We reasoned, however, that this ``STL motif'' alone was not sufficient to direct internalization because our deletion mutant (Del315-329) displayed markedly reduced endocytosis (t = 8.6 min, Y(max) = 40.9%), despite the presence of this tripeptide sequence as well as other contributing residues, Thr and Ser(23) . Thus, we focused on identifying specific residues in the more proximal regions of the carboxyl-tail. The first point mutants constructed were Tyr to alanine (Y302A) and Lys to alanine (K325A). The rationale for altering these specific residues was that Tyr is a highly conserved residue in many G-protein-coupled receptors and because the analogous Tyr in the beta(2)-adrenergic receptor has been identified as a key residue in the internalization process(25) . The K325A mutant was engineered because: 1) this amino acid is present in the configuration AKS which is similar to the internalization motif DAKSS(34) , with its crucial central lysine, found in the yeast alpha-factor receptor, also a seven transmembrane spanning protein like AT; and 2) Lys is located within the region(315-329) identified as important for AT receptor endocytosis. Shown in Fig. 4are the internalization profiles for Y302A and K325A compared to the wild type receptor. The internalization kinetics for the K325A mutant were equivalent (t 2.8 min, Y(max) 73.5%) to the wild type receptor, suggesting that this residue is not critical for internalization. The Y302A mutation had little effect on AT internalization; the rate was slightly reduced (t 4.2 min), but the maximal level of receptor endocytosis was comparable (Y(max) 81.7%) to wild type.


Figure 4: Single point mutants Y302A and K325A and the wild type AT receptor display similar endocytosis. Internalization kinetics for CHO-K1 cells stably expressing the wild type (filled circles), Y302A (open circles), and K325A (open squares) AT receptors were determined as described in the legend to Fig. 1. Data are the means ± S.D. from three separate experiments performed in triplicate.



Given the prevalence of tyrosine residues in the endocytotic motifs for many receptors(3, 5) , we next mutated Tyr and Tyr separately to alanines. Also, for some receptors (e.g. insulin(35) ), dileucine residues within the cytoplasmic regions are important for efficient receptor internalization. Since the AT receptor carboxyl terminus includes a dileucine pair (LeuLeu) and because these leucines are located between residues 315-329, we decided to test the involvement of this putative motif by mutating Leu to another hydrophobic residue, phenylalanine (L316F). Shown in Fig. 5are the internalization profiles for Y312A, L316F, and Y319A. Mutation Y312A internalized at a rate (t 2.8 min) and to a degree (Y(max) 67.8%) comparable with the wild type receptor. Mutation L316F displayed a significantly reduced capacity for endocytosis with a 2.5-fold reduction in rate (t 6.1 min) and a diminished maximal level (Y(max) 38.1%). The internalization rate (t 6.2 min) for Y319A was also reduced, but the Y(max) at 71.4% was similar to that of the wild type receptor.


Figure 5: Comparison of endocytosis for wild type AT receptors and Y312A, L316F and Y319A mutants. Internalization kinetics for CHO-K1 cells stably expressing the wild type (filled circles), Y312A (open circles), L316F (open squares), and Y319A (filled squares) AT receptors were determined as described in the legend to Fig. 1. Data are the means ± S.D. from three separate experiments performed in triplicate.



The results presented above implicate Leu and Tyr in the control of AT receptor endocytosis. These observations were confirmed in other clonal lines expressing these two mutations, but as further confirmation that our observations are not the result of aberrations arising from clonal selection, we performed transient transfections for selected constructs. CHO-K1 cells were transfected using lipofectamine reagent with pRc/AT (wild type) or DNA for mutated receptors (pRc/TL314, pRc/TK333, pRc/Del315-329, pRc/L316F, and pRc/Y319A), and 48 h after transfection internalization assays were performed. The amount of internalization was determined at 10 min, the time of maximal endocytosis for the wild type receptor. As shown in Fig. 6, the results of transient assays closely mirrored the data obtained with the clonal cell lines. Thus, compared to wild type (66.8%), TK333 (28.1%) exhibited reduced endocytosis, but not to the level displayed by TL314 (9.6%) and Del315-329 (6.8%). Moreover, the single point mutations L316F (26.8%) and Y319A (46.1%) showed diminished internalization which was comparable to that observed in clonal counterparts at 10 min.


Figure 6: Endocytosis of the wild type AT receptor and various truncated, deleted, and point mutants following transient transfection in CHO-K1 cells. CHO-K1 cells were transfected with plasmid DNA encoding wild type (pRc2A/AT), truncated (pRc/TL314 and pRc/TK333), deleted (pRc/Del315-329), and point mutated (pRc/L316F and pRc/Y319A) AT receptors, and 48 h later internalization assays were performed as described under ``Experimental Procedures.'' The percentage internalization for mutant receptors was determined 10 min after addition of I-AII at 37 °C, a time where internalization of the wild type was maximal. Data are the means ± S.D. for duplicate determinations of the number of experiments shown on the graph, except for TK333 which is the mean only of data (28.1 and 28.2%) from two experiments performed in duplicate.




DISCUSSION

The rapid (t 2.5 min) internalization of AIIbulletAT receptor complexes observed in this study reflects the dramatic agonist-stimulated endocytosis observed with many GPCRs, including endogenous and cloned AII receptors(15, 16, 17, 18, 19, 20, 21, 22, 23, 24) . It is generally accepted that internalizing receptors contain motifs or ``codes'' (3, 5) that are recognized by adaptor proteins which mediate the selective aggregation and association of ligand-bound receptors into clathrin-coated pits. These pits then invaginate to form vesicles which fuse with endosomes/lysosomes where low pH dissociates ligand from receptor. The receptor and ligand are then either degraded, or the receptor is recycled back to the cell membrane and the ligand, in the case of AII, may serve to activate putative cytoplasmic (36) or nuclear (37) receptors. While alanine scanning has identified some residues that are required for efficient internalization of some GPCRs, no consensus motif has emerged. In this study, we have identified two disparate regions of the AT receptor involved in AII-stimulated endocytosis. One region is approximately 10 amino acids from the cytoplasmic face of the membrane and involves the hydrophobic residue Leu and the aromatic Tyr, while the other site is more distally located within the serine/threonine-rich region of the receptor tail.

Our observation that two distinct regions of the cytoplasmic tail are important for internalization corroborates accumulating evidence for multiple endocytotic codes in other receptors. For example, the cytoplasmic domain of the insulin receptor contains two tyrosine-based internalization motifs (GPLY and NPEY) and a juxtamembrane dileucine motif (EKITLL)(35) . Similarly, the carboxyl-terminal region of the epidermal growth factor receptor contains at least three endocytotic codes as well as distinct regions for lysosomal targeting(11) . Endocytosis of the mannose-6-phosphate receptor requires two separate regions containing aromatic residues(38) . In addition to receptors with two or more positive internalization codes, some receptors also display both positive and negative regulatory motifs(39, 40, 41) . Our observation of two positive internalization ``motifs'' for the AT receptor most readily compares to another GPCR, the thyrotrophin-releasing hormone receptor(42) . In this receptor, two dissimilar positive sites are also important for endocytosis: one membrane proximal and another more distal site involving serine and threonine residues. The similarity of AT and thyrotrophin-releasing hormone receptors also includes the spacing from the membrane of the first site (10 amino acids) and distance of the two sites from each other in the cytoplasmic tail (20 amino acids). Whether this arrangement is exploited by other GPCRs and the possible interaction between these two sites and the endocytotic machinery remains to be established.

In the pursuit of a universal GPCR internalization motif, Barak et al.(25) recently reported that Tyr, located near the junction of the seventh transmembrane segment and the cytoplasmic tail, is a key residue for the rapid internalization of beta(2)-adrenergic receptors. This observation has particular relevance because many GPCRs possess an analogous tyrosine residue within a highly conserved NPX(2)Y motif (where X is any amino acid). This motif is similar to the NPXY internalization motif, first described for the low density lipoprotein receptor(43) , which is present within the cytoplasmic domains of many receptors. However, we observed in this study that mutation of the corresponding residue (Tyr) in the AT receptor had little effect on the kinetics of AII-stimulated internalization. This observation suggests that Tyr (NPLFY) does not input significantly into AII-stimulated AT receptor endocytosis, and given that a similar motif (NPFLY) is maintained in the AT(2) receptor, which does not internalize(23) , provides further evidence that other sites are responsible for internalization of AT receptors. Indeed, the NPX(2)Y motif may only function for a subset of GPCRs because the comparable tyrosine mutation in the gastrin releasing peptide receptor was also ineffective in modulating endocytosis(44) , and because a subgroup of GPCRs (e.g. receptors for secretin, glucagon, parathyroid hormone, calcitonin, etc.) which lack the NPX(2)Y motif display rapid internalization in response to agonist.

Our observation that one of the two sites important for internalization is located distal to Lys within the terminal 26 amino acids complements the recent findings of Hunyady et al.(23) . Using serial truncations and point mutations of the AT receptor, they identified an important contribution of residues in the region Thr-Ser, with a major involvement of the tripeptide sequence SerThrLeu. However, our observation that TK333 (removal of 26 amino acids) still displayed some internalization, at a level greater than observed for TL314 (deletion of 45 amino acids), suggested that more proximal sites in the carboxyl terminus were also involved. We therefore engineered a deletion mutant in which the terminal 30 amino acids of the AT receptor, including all residues (Thr-Ser) identified as important by Hunyady et al.(23) , were joined to the receptor truncated after Leu. We hypothesized that if the Thr-Ser region was sufficient for endocytosis, then attachment of these sequences to the noninternalizing truncated receptor would rescue the internalization response. Such transplantation of putative internalization motifs onto internalization incompetent receptors has been previously used to positively identify such sites(45, 46, 47) . In contrast, we noted that the endocytosis of this deletion mutant, while apparent, was markedly reduced in comparison to wild type and was slightly less than TK333. These results suggest that the region between Gln and Ser is as important as the more distal STL motif and also raise the possibility that the two regions may be cooperative for endocytosis.

Our observation of a second site within the AT receptor tail is novel. Moreover, we have identified a key role for residues Leu and Tyr which is consistent with the use of aromatic and hydrophobic residues for internalization motifs(3, 5) . Single point mutation of Leu potently inhibited AII-stimulated endocytosis with equivalent efficacy to the large deletion (Del315-329) and truncation (TK333) mutants. Thus, this and surrounding residues represent attractive candidates for the AII internalization motif. What is particularly interesting is that Leu is part of a dileucine pair (LeuLeu), which is a motif utilized by insulin receptors (35) and the IgG receptor FcRI (48) for endocytosis. A role of LeuLeu is supported by the observation that this dileucine pair is not conserved in the noninternalizing rat AT(2) receptor(23) . Further studies will be required to determine whether this region is the actual motif engaged by the endocytotic machinery or whether the deleterious effect of this mutation is secondary to conformational changes which prevent interaction with other sites.

Based on computer modeling and NMR analysis of peptide sequences, internalization motifs are proposed to involve a type I beta-turn with an exposed aromatic (tyrosine) residue(5) . We have used the computer modeling method of Rost and Sander (30, 31, 32) to predict the secondary structure of the cytoplasmic tail of the AT receptor. The seventh transmembrane segment of the 359 amino acid AT receptor exits the cell membrane around Leu leaving a cytoplasmic carboxyl terminus of 54 amino acids. The region immediately adjacent to the membrane, between Lys and Ile, displayed a high probability of forming an alpha-helix which was terminated by consecutive proline residues (ProPro), while the remainder of the cytoplasmic tail was predicted to form an extended loop structure. As shown in Fig. 7, plotting residues Lys through Ile as a helical wheel reveals an amphipathic nature to this putative helix. The helix divides symmetrically into one side containing exclusively hydrophobic and aromatic side chains (Leu, Ile, Phe, and Tyr) with the other half containing mostly basic (Lys) amino acids. It is interesting that residues Leu and Tyr, which we have shown are important for AT receptor endocytosis, are closely positioned (within 60°) toward the end of this helix. The hydrophobic residues on this aspect would be expected to be protected from the aqueous environment by burying them away from the surface. Alternatively, these hydrophobic residues may be concealed through interaction with other proteins, since amphipathic helices are often involved in protein-protein interactions. Presumably, ligand binding leads to allosteric changes which expose these sites to the endocytotic machinery.


Figure 7: Helical wheel representation of the region Lys through Ile in the carboxyl terminus of the AT receptor. The wheel was constructed assuming a 100 degree turn/residue, based on the prediction that this region is alpha-helical. Note that the helix can be divided into predominately basic and hydrophobic aspects, and the close proximity of Leu and Tyr (boxed) on the hydrophobic side. Amino acids are represented by the single-letter code (K = Lys, Q = Gln, L = Leu, Y = Tyr, F = Phe, and I = Ile).



While a helical prediction for this region of the AT receptor contradicts the current dogma of a tyrosine-based beta-turn as the internalization motif, such a possibility is supported by the recent NMR data of Wilde et al.(49) . These authors synthesized a 21-amino-acid peptide corresponding to the carboxyl terminus of TGN38, a type I integral membrane protein that recycles between the plasma membrane and the trans-Golgi network. This peptide which contained the sequence YQRL analogous to the common internalization motif YXXhyro (hydro = hydrophobic amino acid) displayed a NMR spectra consistent with a helical, not beta-turn, conformation. Regardless of secondary structure, the region corresponding to the terminal end (Phe-Pro) of this putative AT receptor helix, as noted by Hjorth et al. ( Fig. 3of 50), is preserved across species and among subtypes of AT(1) receptors, which is indicative of conserved function. Based on our mutational data and given that this region is not conserved in the noninternalizing AT(2) receptor(23) , the function of this region may be internalization.

Recent studies demonstrating the association of epidermal growth factor receptors with the adaptor complex AP2 of the endocytotic machinery (10, 12) , and another using kinase-deficient epidermal growth factor receptors(11) , have provided evidence that receptor endocytotic motifs are masked in the absence of ligand binding. Occupancy of receptors by ligand promotes an allosteric change which favors exposure of internalization motifs to the endocytotic apparatus and also causes autophosphorylation which amplifies the conformational changes and internalization. Although GPCRs lack intrinsic kinase activity, many are rapidly phosphorylated by cellular kinases on serine, threonine, and tyrosine residues in response to agonist(51) , and there is evidence suggesting a role for phosphorylation in endocytosis. For example, mutation of serine/threonine residues in the beta(2)-adrenergic receptor inhibits internalization(52) , the serine/threonine region of the gastrin releasing peptide receptor is required for endocytosis(53) , and phosphorylation of M2 receptors by the specific receptor kinase GRK2 coincides with increased rates of internalization(54) . Thus, in the general context of an internalization mechanism, phosphorylation of GPCRs appears to augment endocytosis. One interpretation of our data, which identified two carboxyl-terminal regions (one hydrophobic and one serine/threonine-rich) important for AT receptor endocytosis, could be that upon AII binding a conformation change occurs which leads to exposure of the hydrophobic residues and initiates internalization. In addition, this conformational change presumably promotes phosphorylation of the distal phosphate acceptor residues which may maintain this exposed state. Conversely, an allosteric change in this putative helical region may be required for phosphorylation of distant sites, permitting the phosphorylated residues to interact directly with the endocytotic machinery. However, the propensity of hydrophobic and tyrosine residues in the internalization motifs of many receptors predicts that the former possibility is more likely.

In summary, we have identified two distinct regions of the AT receptor necessary for the efficient endocytosis of AIIbulletAT receptor complexes and demonstrated a central role for Leu and Tyr in this process. These residues are closely aligned on the hydrophobic face of a putative alpha-helix. Future studies will focus on identifying a role for AT receptor phosphorylation in internalization and the possible interaction of the AT receptor with the adaptor complexes that initiate the clustering and endocytosis process. The truncated, deleted, and point-mutated AT receptors described in this study should prove useful in delineating these processes for the AT receptor and may provide a more general understanding of the process of endocytosis for other GPCRs.


FOOTNOTES

*
This work was supported by the Geisinger Clinic Foundation and by Grant AHA94013470 from the American Heart Association (to T. J. T.) and Grant HL44883 from the National Institutes of Health (to K. M. B.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore by hereby marked ``advertisement'' in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

§
Recipient of a C. J. Martin Fellowship from the National Health and Medical Research Council of Australia.

K.M.B. is an Established Investigator of the American Heart Association.

**
To whom correspondence should be addressed: Dept. of Medicine, C281, University of Colorado Health Sciences Center, 4200 E. Ninth Ave., Denver, CO 80262. Tel.: 303-436-5902.

(^1)
The abbreviations used are: AII, angiotensin II; AT, angiotensin II receptor subtypes; G-protein, guanyl nucleotide-binding protein; GCPR(s), G-protein coupled receptor(s); CHO-K1, Chinese hamster ovary cells; G418, geneticin; MEM, minimal essential medium; PCR, polymerase chain reaction.


REFERENCES

  1. Goldstein, J. L., Brown, M. S., Anderson, R. G. W., Russel, D. W., and Schneider, W. J. (1985) Annu. Rev. Cell Biol. 1,1-39 [CrossRef]
  2. Pearse, B., and Robinson, M. S. (1990) Annu. Rev. Cell Biol. 6,151-171 [CrossRef]
  3. Trowbridge, I. S. (1991) Curr. Opin. Cell Biol. 3,634-641 [Medline] [Order article via Infotrieve]
  4. Smythe, E., and Warren, G. (1991) Eur. J. Biochem. 202,689-699 [Medline] [Order article via Infotrieve]
  5. Vaux, D. (1992) Trends Cell Biol. 2,189-192 [CrossRef][Medline] [Order article via Infotrieve]
  6. Sorkin, A., and Water, C. M. (1993) BioEssays 15,375-382 [Medline] [Order article via Infotrieve]
  7. Pley, U., and Parham, P. (1993) Crit. Rev. Biochem. Mol. Biol. 28,431-464 [Abstract]
  8. Robinson, M. (1994) Curr. Opin. Cell Biol. 6,538-544 [Medline] [Order article via Infotrieve]
  9. Roettger, B. F., Rentsch, R. U., Pinon, D., Holicky, E., Hadac, E., Larkin, J. M., and Miller, L. J. (1995) J. Cell Biol. 128,1029-1041 [Abstract]
  10. Sorkin, A., McKinsey, T., Shih, W., Kirchhausen, T., and Carpenter, G. (1995) J. Biol. Chem. 270,619-625 [Abstract/Free Full Text]
  11. Opresko, L. K., Chang, C., Will, B. H., Burke, P. M., Gill, G. N., and Wiley, H. S. (1995) J. Biol. Chem. 270,4325-4333 [Abstract/Free Full Text]
  12. Nesterov, A., Kurten, R. C., and Gill, G. N. (1995) J. Biol. Chem. 270,6320-6327 [Abstract/Free Full Text]
  13. Robertson, J. I. S., and Nicholls, M. G. (eds) (1993) The Renin-Angiotensin System , Vol. 1, Biochemistry and Physiology, Gower Medical Publishing, London
  14. Sandberg, K. (1994) Trends Endocrinol. Metab. 5,28-35
  15. Crozat, A., Penhoat, A., and Saez, J. M. (1986) Endocrinology 118,2312-2318 [Abstract]
  16. Griendling, K. K., Delafontaine, P., Rittenhouse, S. E., Gimbrone, M. A., Jr., and Alexander, R. W. (1987) J. Biol. Chem. 262,14555-14562 [Abstract/Free Full Text]
  17. Ullian, M. E., and Linas, S. E. (1989) J. Clin. Invest. 84,840-846 [Medline] [Order article via Infotrieve]
  18. Hunyady, L., Merelli, F., Baukal, A. J., Balla, T., and Catt, K. J. (1991) J. Biol. Chem. 266,2783-2788 [Abstract/Free Full Text]
  19. Anderson, K. M., Murahashi, T., Dostal, D. E., and Peach, M. J. (1993) Am. J. Physiol. 284,C179-188
  20. Conchon, S., Monnot, C., Teutsch, B., Corvol, P., and Clauser, E. (1994) FEBS Lett. 349,365-370 [CrossRef][Medline] [Order article via Infotrieve]
  21. Hunyady, L., Tian, Y., Sandberg, K., Balla, T., and Catt, K. J. (1994) Kidney Int. 46,1496-1498 [Medline] [Order article via Infotrieve]
  22. Hunyady, L., Baukal, A. J., Balla, T., and Catt, K. J. (1994) J. Biol. Chem. 269,24798-24804 [Abstract/Free Full Text]
  23. Hunyady, L., Bor, M., Balla, T., and Catt, K. J. (1994) J. Biol. Chem. 269,31378-31382 [Abstract/Free Full Text]
  24. Thomas, W. G., Thekkumkara, T. J., Motel, T. J., and Baker, K. M. (1995) J. Biol. Chem. 270,207-213 [Abstract/Free Full Text]
  25. Barak, L. S., Tiberi, M., Freedman, N. J., Kwatra, M. M., Lefkowitz, R. J., and Caron, M. G. (1994) J. Biol. Chem. 269,2790-2795 [Abstract/Free Full Text]
  26. Thekkumkara, T. J., Du, J., Dostal, D. E., Motel, T. J., Thomas, W. G., and Baker, K. M. (1995) Mol. Cell. Biochem. 146,79-89 [Medline] [Order article via Infotrieve]
  27. Ito, W., Ishiguro, H., and Kurosawa, Y. (1991) Gene (Amst.) 102,67-70 [CrossRef][Medline] [Order article via Infotrieve]
  28. Schorb, W., Booz, G. W., Dostal, D. E., Conrad, K. M., Chang, K. C., and Baker, K. M. (1993) Circ. Res. 72,1245-1254 [Abstract]
  29. Swillens, S. (1992) Trends Pharmacol. Sci. 13,430-434 [Medline] [Order article via Infotrieve]
  30. Rost, B., and Sander, C. (1993) J. Mol. Biol. 232,584-599 [CrossRef][Medline] [Order article via Infotrieve]
  31. Rost, B., Sander, C., and Schneider, R. (1994) Comput. Appl. Biosci. 10,53-60 [Abstract]
  32. Rost, B., and Sander, C. (1994) Proteins 19,55-72 [Medline] [Order article via Infotrieve]
  33. Catt, K. J. (1993) in The Renin-Angiotensin System: Biochemistry and Physiology (Robertson, J. I. S, and Nicholls, M. G., eds) Vol. 1, 12.1-12.14, Gower Medical Publishing, London
  34. Rohrer, J., Benedetti, H., Zanolari, B., and Riezman, H. (1993) Mol. Biol. Cell 4,511-521 [Abstract]
  35. Haft, C. R., Klausner, R. D., and Taylor, S. I. (1994) J. Biol. Chem. 269,26286-26294 [Abstract/Free Full Text]
  36. Sugiura, N., Hagiwara, H., and Hirose, S. (1992) J. Biol. Chem. 267,18067-18072 [Abstract/Free Full Text]
  37. Booz, G. W., Conrad, K. M., Hess, A. L., Singer, H. A., and Baker, K. M. (1992) Endocrinology 130,3641-3649 [Abstract]
  38. Johnson, K. F., Chan, W., and Kornfeld, S. (1990) Proc. Natl. Acad. Sci. U. S. A. 87,10010-10014 [Abstract]
  39. Green, S. A., and Liggett, S. B. (1994) J. Biol. Chem. 269,26215-26219 [Abstract/Free Full Text]
  40. Huang, Z., Chen, Y., and Nissenson, R. A. (1995) J. Biol. Chem. 270,151-156 [Abstract/Free Full Text]
  41. Parker, E. M., Swigart, P., Nunnally, M. H., Perkins, J. P., and Ross, E. M. (1995) J. Biol. Chem. 270,6482-6487 [Abstract/Free Full Text]
  42. Nussenzveig, D. R., Heinflink, M., and Gershengorn, M. C. (1993) J. Biol. Chem. 268,2389-2392 [Abstract/Free Full Text]
  43. Chen, W., Goldstein, J. L., and Brown, M. S. (1990) J. Biol. Chem. 265,3116-3123 [Abstract/Free Full Text]
  44. Slice, L. W., Wong, H. C., Sternini, C., Grady, E. F., Bunnett, N. W., and Walsh, J. H. (1994) J. Biol. Chem. 269,21755-21762 [Abstract/Free Full Text]
  45. Collawn, J. F., Kuhn, L. A., Liu, L. S., Trainer, J. A., and Trowbridge, I. S. (1990) EMBO J. 10,3247-3253 [Abstract]
  46. Trowbridge, I. S., Collawn, J. F., and Hopkins, C. R. (1993) Annu. Rev. Cell Biol. 9,126-161
  47. Lai, A., Sisodia, S. S., and Trowbridge, I. S. (1995) J. Biol. Chem. 270,3565-3573 [Abstract/Free Full Text]
  48. Hunziker, W., and Fumey, C. (1994) EMBO J. 13,2963-2969 [Abstract]
  49. Wilde, A., Dempsey, C., and Banting, G. (1994) J. Biol. Chem. 269,7131-7136 [Abstract/Free Full Text]
  50. Hjorth, S. A., Schambye, H. T., Greenlee, W. J., and Schwartz, T. W. (1994) J. Biol. Chem. 269,30953-30959 [Abstract/Free Full Text]
  51. Premont, R. T., Inglese, J., and Lefkowitz, R. J. (1995) FASEB J. 9,175-182 [Abstract/Free Full Text]
  52. Yu, S. S., Lefkowitz, R. J., and Hausdorff, W. P. (1993) J. Biol. Chem. 268,337-341 [Abstract/Free Full Text]
  53. Benya, R. V., Fathi, Z., Battey, J. F., and Jensen, R. T. (1993) J. Biol. Chem. 268,20285-20290 [Abstract/Free Full Text]
  54. Tsuga, H., Kameyama, K., Haga, T., Kurose, H., and Nagao, T. (1994) J. Biol. Chem. 269,32522-32527 [Abstract/Free Full Text]
  55. Bradford, M. M., (1976) Anal. Biochem. 72,248-254 [CrossRef][Medline] [Order article via Infotrieve]

©1995 by The American Society for Biochemistry and Molecular Biology, Inc.